News & Medical Papers
For current guidelines and updates from within the arrhythmia healthcare community please visit Arrhythmia Watch.
Lower stroke risk with paroxysmal AF?
medscape.com, 15 December 2014
More evidence suggesting that intermittent atrial fibrillation (AF) may be associated with a lower risk for stroke compared with permanent AF has come from a new systematic review of the literature.
Working Life: Dr Dermot McCaffrey, consultant cardiologist, Beacon Hospital
irishexaminer.com, 13 December 2014
A day in the life of Dr Dermot McCaffrey.
Why the sudden onset bruising in a previously stable warfarin patient?
medscape.com, 12 December 2014
A 72-year-old man is your last patient of the day. He is visiting his daughter, a patient of yours, who asks you to see him.
Atrial fibrillation specific follow-up plan improves post-discharge survivability
hcplive.com, 12 December 2014
Research shows that a follow-up strategy designed specifically for patients who visit the hospital with atrial fibrillation (AF) reduces future admissions and patient deaths more than a general follow-up plan.
Newer ICD leads associated with low rates of mechanical failure
healio.com, 12 December 2014
Optim-insulated implantable cardioverter defibrillator leads had low rates of all-cause mechanical failure and no observed externalized conductors in a registry study.
How useful is the RED-AF tool for improving outcomes in patients with atrial fibrillation?
hcplive.com, 10 December 2014
Researchers from Vanderbilt University have developed a new tool for deciding when hospitals should admit patients with symptomatic atrial fibrillation (AF) and when they should send them home.
Dual-chamber settings in ICDs reduced risk for inappropriate shock
healio.com, 11 December 2014
Compared with single-chamber settings, dual-chamber settings for implantable cardioverter defibrillators were associated with reduced risk for inappropriate shock without increases in morbidity and mortality, according to the results of the OPTION study.
Biotronik completes full-body ProMRI pacemaker trial
zenopa.com, 11 December 2014
Biotronik has announced the completion of the latest phase of its new ProMRI study, which assesses cardiovascular medical technology equipped with its ProMRI technology.
Reducing the risk of sudden cardiac arrest during sports
news-medical.net, 11 December 2014
Time and again, the topic of sudden cardiac death grabs the public's attention when football stars or other top athletes collapse from cardiac arrest in front of the live cameras.
Risk of mortality and cardiovascular outcomes among patients newly diagnosed with atrial fibrillation
BJCardio.co.uk, December 2014
This study aimed to assess mortality and cardiovascular (CV) outcomes of patients with newly diagnosed atrial fibrillation (AF) managed in the UK primary care setting.
Real-world use affirms NOAC safety profile
medpagetoday.com, 9 December 2014
The bleeding risk profile seen with dabigatran (Pradaxa) and rivaroxaban (Xarelto) in trials of prevention in atrial fibrillation was affirmed in real-world practice.
BIOTRONIK Announces Conclusion of Full-Body ProMRI Pacemaker Study
businesswire.com, 9 December 2014
BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced today that Phase B of its ProMRI® study has completed patient enrollment and concluded all planned scans. This phase of the study is investigating the safety of Entovis pacemakers in patients who undergo full-body magnetic resonance imaging (MRI) scans, including cardiac and thoracic spinal scans.
Study examines patients’ perspectives on deactivation of implantable defibrillators in end-of-life scenarios
dicardiology.com, 5 November 2014
Most patients with implantable cardioverter defibrillators (ICDs) haven’t thought about device deactivation if they were to develop a serious illness from which they were not expected to recover. But given changes in healthcare, there may be a new reason to do so.
Survey: Doctors believe patients with AF underestimate stroke risk, impact
healio.com, 5 December 2014
Many physicians said they believe that patients with atrial fibrillation underestimate the effect of atrial fibrillation-related stroke on their daily lives and underestimate their risk for ischemic stroke, according to the results of a new survey.
Unlocking the potential of NOACs
BJCardio.co.uk, December 2014
When the NOACs (novel oral anticoagulants) were introduced over three years ago, they promised to revitalise the management of conditions such as atrial fibrillation (AF), venous thromboembolism (VTE) and thromboprophylaxis after major joint replacement surgery.
Stroke prevention project in Bradford highlighted in European report
telegraphandargus.co.uk, 4 December 2014
A HIGH-PROFILE European report is highlighting a project being pioneered in Bradford to help prevent strokes in people with a common heart rhythm disorder.
iRhythm Technologies Receives CE Mark for ZIO® Service, Enters First International Market with CardioLogic Ltd Partnership in United Kingdom
prnewswire.com, 3 December 2014
iRhythm Technologies, Inc., a leading digital health care solutions company focusing on the advancement of cardiac care, today announced that it has secured a CE mark (Conformite Europeenne) for the ZIO Service, enabling the company to market its long-term continuous heart monitoring solution in Europe.
Epinephrine hurts cardia carrest survival?
medpagetoday.com, 2 December 2014
Epinephrine (adrenaline) given before hospital arrival for cardiac arrest was associated with poorer chances of survival without substantial mental disability, an observational study showed.
Cryoballoon procedure quicker to perform than coventional ablation
MailOnline.co.uk, 2 December 2014
Atrial fibrillation — an erratic heartbeat — affects up to 800,000 Britons, and can lead to a stroke if left untreated.
ARREST-AF study shows reducing bad lifestyle choices helps improve long-term success rates of ablation procedures for AF
medpagetoday.com, 1 December 2014
Aggressively tackling weight, blood pressure, and other cardiovascular risk factors improved the long-term success of ablation procedures for atrial fibrillation, the ARREST-AF study showed.
Biotronik's new ProMRI ICDs and CRT-Ds unveiled
medgadget.com, 1 December 2014
BIOTRONIK announced that it is releasing a new line of ProMRI implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).
New study on warfarin use in treatment of AF
hcplive.com, 30 November 2014
For patients diagnosed with atrial fibrillation, one of the more popular treatment courses is warfarin.
GPs urged to discontinue aspirin in stable CAD patients with atrial fibrillation
pulsetoday.co.uk, 24 November 2014
GPs have been cautioned against continuing aspirin long-term in patients with stable coronary artery disease (CAD) who are also receiving anticoagulation therapy for stroke prevention.
Findings of PROTECT AF study at 4 years show LAA closure maintains efficacy over warfarin
tctmd.com, 20 November 2014
Adding another layer to the body of evidence, 4-year results from the PROTECT AF trial showing better efficacy for patients with nonvalvular atrial fibrillation (A-fib) using percutaneous left atrial appendage (LAA) closure compared with warfarin were published in the November 19, 2014, issue of the Journal of the American Medical Association.
Job vacancy: Anticoagulant Nurse Practitioner
The Royal Liverpool and Broadgreen University Hospitals, November 2014
Band 7, closes 3 December 2014
The Royal Liverpool and Broadgreen University Hospitals NHS Trust is one of the largest and busiest hospital trusts in the North of England with an annual budget of over £300 million, more than 7,000 staff and almost one million patients being seen every year. We employ approximately 300 consultants, many of whom have honorary senior lecturer contracts with the University of Liverpool.
New study investigates patient perspectives on deactivation of ICDs at the end of life
news-medical.net, 18 November 2014
Findings point to need for advance care planning around device deactivation
Penn study examines patients' perspectives on deactivation of implantable defibrillators in end-of-life scenarios
healthcanal.com, 18 November 2014
Findings point to need for advance care planning around device deactivation.
Anticoagulation highlights from ESC 2014
BJCardio.co.uk, November 2014
Much of the European Society of Cardiology (ESC) 2014 Congress programme was devoted to important clinical issues such as management of arrhythmia, and stroke prevention in non-valvular atrial fibrillation (NVAF).
Overuse of anticoagulants raises dementia risk in AF patients
gponline.com, 16 November 2014
Long-term overtreatment with anticoagulants combined with antiplatelet therapy to prevent stroke could increase the risk of dementia in patients with AF, researchers have found.
Drug lowers high potassium levels associated with potentially lethal cardiac arrhythmias
medicalxpress.com, 17 November 2014
Mikhail Kosiborod, M.D., of Saint Luke's Mid America Heart Institute, Kansas City, and colleagues evaluated the efficacy and safety of the drug zirconium cyclosilicate in patients with hyperkalemia (higher than normal potassium levels).
CCGs in the dark about demand for, and quality of, anticoagulation services
onmedica.com, 17 November 2014
Clinical Commissioning Groups are in the dark about how many people in their local area are at risk of a stroke caused by an abnormal heartbeat, or the quality of services provided to treat them, finds a new report* issued by charity AntiCoagulation Europe (ACE).
Relative value of clinical outcomes with anticoagulants varies among patients
medscape.com, 13 November 2014
In an assessment of the relative value and weight of clinical events associated with anticoagulant therapy, not all outcomes are created equally in the minds of patients, according to the results of a unique experiment.
A pacemaker powered by heart motion is being developed
cxvascular.com, 13 November 2014
Researchers in Switzerland are developing a pacemaker which has no leads and no battery. With this in mind, the prototype is aimed to solve two of the major problems with traditional pacemakers.
Continuous ECG surveillance of marathon athletes is feasible
cxvascular.com, 13 November 2014
Online electrocardiogram (ECG) continuous surveillance during marathon running is feasible, according to a study presented at the European Congress on e-Cardiology and e-Health (29–31 October, Bern, Switzerland).
AliveCor® to showcase the AliveCor Heart Monitor at the American Heart Association scientific sessions
prnewswire.com, 15 November 2014
AliveCor, Inc. announced today its attendance at the American Heart Association Scientific Sessions taking place at McCormick Place in Chicago, Ill. from November 15-19.
AF associated with accelerated renal disease
hcplive.com, 15 November 2014
A common arrhythmia in older adults is more common in those with chronic kidney disease (CKD) and may speed progression to the need for kidney dialysis or transplant, according to Nisha Bansal, MD.
Study finds link between AF and Silent Cerebral Infarctions
hcplive.com, 12 November 2014
A meta-analysis of many older studies may explain the recent observation that patients with atrial fibrillation (AF) frequently suffered cognitive impairment without suffering from any signs of stroke.
New blood test reveals risk of AF and stroke
hcplive.com, 10 November 2014
New research suggests that a simple blood test could identify people with a genetic predisposition towards atrial fibrillation (AF) and justify prophylactic treatment to cost-effectively prevent strokes.
New plan to send more patients wiith AF home
medscape.com, 6 November 2014
A new clinical tool could help physicians decide which patients with symptomatic atrial fibrillation can safely be sent home from the emergency department, according to a new study.
Another antidote for new oral anticoagulants advances in phase 1 study
medscape.com, 6 November 2014
It took about 10 minutes for a single 100- to 300-mg dose of a synthetic anticoagulant antidote to mostly restore clotting time prolonged by 60 mg of edoxaban (Savaysa, Daiichi Sankyo), a new oral anticoagulant (NOAC) that seems destined to soon join others on the market, in a phase 1 study reported preliminarily this week.
Three wearables that could change AF screening
medpagetoday.com, 5 November 2014
In this 3-part series, we'll look first at current screening strategies and some of the limitations that create an opportunity for emerging tools. Then we'll dive into some of the tools that will define the next generation of atrial fibrillation screening.
Defibrillator implantation riskier on afternoons, weekends
medscape.com, 5 November 2014
Defibrillator-implantation procedures are associated with worse in-hospital outcomes when they're performed on weekends and afternoons than on weekdays and mornings, a new study shows.
Smartphone screening for AF?
medpagetoday.com, 4 November 2014
In this three-part series, we'll look first at current screening strategies and some of the limitations that create an opportunity for emerging tools. Then we'll dive into some of the tools that will define the next generation of atrial fibrillation screening.
AF poised as mobile health success story
medpagetoday.com, 3 November 2014
In this 3-part series, we'll look first at current screening strategies and some of the limitations that create an opportunity for emerging tools. Then we'll dive into some of the tools that will define the next generation of atrial fibrillation screening. This is part 1.
Job vacancy: Anticoagulant Database and Centre Coordinator
Cambridge University Hospitals, November 2014
The outpatient anticoagulant service wishes to recruit a highly motivated person to join their team as a data manager. The service provides care for over 5,000 anticoagulated patients in the community, and is committed to admission avoidance, and transferring care safely into the community after hospitalization.
AtriCure announces upcoming investor conference schedule
businesswire.com, 31 October 2014
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation and Left Atrial Appendage Management, today announced that it will present at the Stifel Healthcare Conference 2014 at the Palace Hotel in New York City on Tuesday, November 18, 2014.
FDA panel endorses edoxaban as fourth NOAC
medpagetoday.com, 31 October 2014
Edoxaban (Savaysa) should be approved for stroke and systemic embolism prevention in nonvalvular atrial fibrillation, an FDA advisory panel recommended Thursday.
FDA gives edoxaban favourable review prior to advisory committee meeting
medscape.com, 29 October 2014
SILVER SPRING, MD — Food and Drug Administration (FDA) officials charged with the task of reviewing edoxaban (Savaysa, Daiichi-Sankyo) in advance of tomorrow's advisory committee meeting are recommending the novel anticoagulant be approved for the treatment of patients with atrial fibrillation (AF).
Improve atrial fibrillation care to stave off 11,000 strokes every year, GPs told
onmedica.com, 30 October 2014
Improving the care of people with abnormal heart rhythms (atrial fibrillation) could stave off more than 11,000 strokes and save the NHS up to £124 million every year, finds a new economic analysis* of using warfarin to help prevent stroke from NHS Improving Quality.
VIDEO: Evolution in catheter ablation of persistent AF, HRC 2014
Arrhythmia & Electrophysiology Review, Heart Rhythm Congress 7 October 2014
Arrhythmia and Electrophysiology Review (AER) Interview with Mark O'Neill, Kings College, London, UK on the evolution in catheter ablation of persistent AF.
VIDEO: The subcutaneous ICD - a revolutionary tool for prevention of sudden cardiac death
Arrhythmia & Electrophysiology Review, Heart Rhythm Congress, 7 October 2014
Arrhythmia and Electrophysiology Review (AER) Interview with Andrew Grace, University of Cambridge on the subcutaneous ICD - a revolutionary tool for prevention of sudden cardiac death.
AliveCor honored as one of FierceMedicalDevices' Fierce 15 most promising private medical and diagnostic companies in the world
prnewswire.com, 21 October 2014
AliveCor, Inc. announced today that the company has been named one of the Fierce 15 most promising privately held medical device and diagnostic companies in the world.
Three ways to prevent sudden heart death in fit, young athletes
medicalxpress.com, 21 October 2014
Fifteen year-old Marshall Hastings is living proof of the value of having life-saving cardiac defibrillators and trained personnel at sporting events.
Liverpool Cardiologist Receives Outstanding National Award
Liverpool Hospitals, 20 October 2014
A heart specialist at Liverpool Heart and Chest Hospital has been recognised nationally for his work in caring for patients with abnormal heart rhythms (arrhythmias).
Amiodarone use increased stroke, systemic embolism risk in patients with AF
healio.com, 20 October 2014
Patients with atrial fibrillation who received amiodarone at baseline in the ARISTOTLE trial, besides apixaban or warfarin, had an increased risk for developing stroke or systemic embolism and had a shorter time in the therapeutic range compared with patients who did not receive amiodarone, according to a new analysis.
Rose Medical Center experts perform LARIAT procedure for patients with atrial fibrillation
news-medical.net, 16 October 2014
Rose Medical Center is now performing a groundbreaking procedure for patients with atrial fibrillation (AFib) that may reduce their risk for stroke when they cannot take blood thinners due to special circumstances.
New guidelines for postoperative atrial fibrillation: key points for pharmacists
pharmacytimes.com, 14 October 2014
The American Association for Thoracic Surgery recently published new recommendations for the prevention and management of atrial fibrillation (AF) and flutter in patients undergoing thoracic surgery.
Check the pulse to track irregular heartbeats after a stroke, from the October 2014 Harvard Heart Letter
digitaljournal.com, 14 October 2014
The rapid, irregular heartbeat known as atrial fibrillation is a key cause of stroke. New research suggests that it's to blame for more strokes than doctors realized, and that simply measuring the pulse could help detect unrecognized atrial fibrillation and avert a second stroke, reports the October 2014 Harvard Heart Letter.
Pharma supports first World Thrombosis Day
pmlive.com, 13 October 2014
The first World Thrombosis Day takes place today with supporters including several pharma companies.
Patients with recurrent AF more likely to have kidney function decline
medicalresearch.com, 13 October 2014
An interview with Dr Jelena Kornej, Department of Electrophysiology, Heart Centre, Leipzig, Germany.
AtriCure completes enrollment in post approval study for the synergy™ ablation system
businesswire.com, 9 October 2014
AtriCure, Inc., a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management (LAAM), today announced enrollment in the ABLATE Post Approval Study (PAS) is complet
Comorbities will be considered in future ACC/AHA Guidelines
healio.com, 8 October 2014
American College of Cardiology/American Heart Association clinical practice guidelines in the future will discuss the applicability and quality of recommendations for the most frequent comorbidities related to the CV condition addressed, according to a new statement from the ACC, the AHA and the US Department of Health and Human Services.
FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device
marketwatch.com, 8 October 2014
After reviewing updated data and analysis for the Boston Scientific Corporation BSX, -1.81% WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device, the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted in favor of the Device. By a vote of 6 to 5 (with 1 abstention) the Panel concluded that the benefits of the WATCHMAN Device outweigh the potential risks.
AF Association Medical Advisory Committee member wins prestigious award
Dr Matthew Fay, a GP with a special interest in AF at Westcliffe Medical Practice in Shipley, West Yorkshire, has been awarded a prestigious Lifetime Achievement Award for his work advancing anticoagulation care.
Dr Fay accepted his award at the Quality in Care (QiC) Anticoagulation Awards ceremony in London on Tuesday 30 September 2014.
AF Association would like to congratulate Dr Fay and all other award winners, including staff at Cloyne Pharmacy, who scooped the Judges' Special Award for their excellent service to patients.
Commissioning through Evaluation
england.nhs.uk, 10 October 2014
NHS England publishes details on centres selected to provide cardiology schemes as part of its £15m Commissioning through Evaluation programme.
ISAR TRIPLE: Shorter duration of triple therapy not superior to longer duration
healio.com, 3 October 2014
Six weeks of triple therapy after DES implantation failed to improve on 6 months of that regimen in terms of net clinical outcomes, according to findings presented at TCT 2014.
Digoxin raised risk for death in ROCKET AF subanalysis
healio.com, 3 October 2014
Patients with atrial fibrillation who used digoxin at baseline in the ROCKET AF trial had increased risks for all-cause mortality, vascular mortality and sudden cardiac death.
Bringing Fabrice Muamba back from the dead
guardian.co.uk, 5 October 2014
Two years ago, Shauna Muamba watched her husband almost die on the pitch at White Hart Lane. The couple talk to Anna Kessel about Fabrice’s long road to recovery – and how it has changed their family dynamic for good.
FDA panel to review new Watchman data
medscape.com, 6 October 2014
The Watchman left atrial appendage closure device (Boston Scientific) is making its third trip to Gaithersburg, MD, Wednesday.
Heart Rhythm Congress 2014 event report
arwatch.co.uk, September 2014
Delegates are invited to attend the 9th annual Heart Rhythm Congress (HRC). The event spans four days and this year will be held from 5th–8th October at the International Convention Centre, Birmingham UK.
AliveCor Launches New App to Auto Detect Atrial Fibrillation in an ECG Recording
digitaljournal.com, 29 September 2014
AliveCor, Inc. announced today the launch of the latest version of the AliveECG app, which provides patients with free real-time atrial fibrillation (AF) detection in ECG recordings using its new FDA-cleared algorithm.
Atrial fibrillation is poised to be a mobile health success story
imedicalapps.com, 25 September 2014
In this three part series, we’ll look first at current screening strategies and some of the limitations that create an opportunity for emerging tools. Then we’ll dive into some of the tools that will define the next generation of atrial fibrillation screening. This is Part 1.
Medtronic SEEQ Continuous Monitoring System Helps Detect Cardiac Arrhythmias
medgadget.com, 19 September 2014
Medtronic is launching in the U.S. the SEEQ Mobile Cardiac Telemetry (MCT) system, a wireless monitor used to detect and analyze cardiac arrhythmias.
PREVAIL Update Less Positive for Watchman
medpagetoday.com, 19 September 2014
More data revealed more failure for the Watchman left atrial appendage (LAA) closure device, but, again, interventional cardiologists attending the Transcatheter Cardiovascular Therapeutics meeting were scouring the rubble for positive signals.
Stroke and Beyond: Cognitive Decline in Patients with Atrial Fibrillation
medpagetoday.com, September 2014
Atrial fibrillation (AF) has been linked to a significantly higher risk of cognitive impairment and dementia in patients with no history of clinical stroke. While research continues into the mechanisms by which AF increases risk of cognitive impairment, stroke prevention remains the focus of efforts to prevent AF-related cognitive decline.
Misperceptions of ICD performance at end of life common among recipients with HF
healio.com, 16 September 2014
Patients in Sweden with an implantable cardioverter defibrillator often have misperceptions about its function at the end of life that could influence decision-making regarding care, according to results presented at the Heart Failure Society of American Annual Scientific Meeting.
European experiences reviewed
bjcardio.co.uk, 9 September 2014
The novel oral anticoagulant (NOAC) agents (dabigatran, rivaroxaban, apixaban) have had a disproportionally poor uptake since their respective launches and National Institute for Health and Care Excellence (NICE) Technology Appraisal in the UK between 2012 and 2013 for their use in stroke prevention in patients with non-valvular atrial fibrillation (NVAF), when compared with our European counterparts; particularly Germany, Holland and France.
Novel oral anticoagulants in daily clinical practice – German experience with rivaroxaban
bjcardio.co.uk, 9 September 2014
Oral anticoagulation has been restricted to vitamin K antagonists (VKAs) for more than 50 years. Starting in the last decade of the past century, central coagulation factors such as thrombin and factor Xa were explored as potential targets for the development of novel oral anticoagulants (NOACs).
Rivaroxaban in non-valvular AF – French experience in perspective
bjcardio.co.uk, 9 September 2014
Vitamin K antagonists (VKAs) reduce the risk of stroke in patients with atrial fibrillation (AF). For more than five decades, they were the only available treatment.
Rivaroxaban in non-valvular AF – UK experience in perspective
bjcardio.co.uk, 9 September 2014
Following the roll-out of the novel oral anticoagulants (NOACs), the European Society of Cardiology (ESC) published in 2012 a focused update of its guidelines for the management of atrial fibrillation (AF).
AMIO-CAT: Short-term amiodarone after AF ablation won't block late AF
medscape.com, 8 September 2014
BARCELONA, SPAIN — Starting patients on an eight-week course of amiodarone immediately after ablation for atrial fibrillation (AF) won't cut the risk of AF recurrence over the next six months, suggested a small study presented here at the European Society of Cardiology (ESC) 2014 Congress.
One in four low-risk atrial fibrillation patients 'inappropriately anticoagulated'
pulsetoday.co.uk, 5 September 2014
More than a quarter of patients with atrial fibrillation who are at low risk of stroke are being ‘inappropriately’ prescribed an oral anticoagulant, a recent audit of UK general practices has claimed.
Heart Stop: Subway Stations Among Best AED Sites In Paris
medscape.com, 5 September 2014
In addition to placing automated external defibrillators (AEDs) in fitness clubs, hockey arenas, and airports, what other type of public facilities are the best sites for these devices, and how many devices would provide the best return on investment?
FDA grants clearance for mobile AF detection algorithm
healio.com, 6 September 2014
AliveCor Inc. announced that it has received clearance from the FDA for an algorithm designed to detect atrial fibrillation using a mobile device.
The 'Just-Because' Use of Beta-blockers Comes Into Question at ESC 2014
medscape.com, 4 September 2014
On clinic days, I sometimes keep a running tally of how many drugs I prescribe and how many I stop. It's usually more than five to one—in favor of stopping.
Anticoagulation services and patient access to INR self-monitoring in the NHS in England
ACSMA, July 2014
There are more than 1.2 million people in the UK on warfarin therapy, of whom fewer than two per cent self-monitor their International Normalised Ratio (INR) level, despite evidence that self-monitoring can cut the risk of death by nearly two-fifths and more than halve the risk of strokes.
Best of ESC Congress 2014
escardio.org, 3 September 2014
Barcelona, 3 September 2014: “The ESC Congress has been a resounding success and I am proud of finishing my presidency on such a high note.” With these words, Prof Vardas said good bye to over 30 300 delegates who attended ESC Congress 2014 in Barcelona, Spain.
GRASP the Initiative Action Plan
2 September 2014: The GRASP-AF tool was designed to support GPs audit their management of AF patients and help identify patients who had presented to their GP, but had not yet been recorded as having AF.The number of GP practices using the GRASP-AF tool has now reached more than 2,600.
This newly launched Action Plan builds on the original GRASP the Initiative report launched by AF Association in October 2012, identifying some of the steps that professionals working in primary care can take after running the GRASP-AF tool in order to optimise the treatment of people with AF registered in their Practice.
New ESC Guidelines on hypertrophic cardiomyopathy
escardio.org, 1 September 2014
The 2014 ESC Guidelines on the diagnosis and management of hypertrophic cardiomyopathy (HCM) are presented for the first time at this congress. The guidelines underscore the multidisciplinary approach to the disease, including imaging, genetics, percutaneous and surgical interventions, device implantations, and pharmacology.
Mass screening identifies untreated AF in 5% of 75-76 year olds
escardio.org, 31 August 2013
Amsterdam, The Netherlands – Saturday 31 August 2013: Mass screening in more than 25,000 Swedish residents has identified untreated atrial fibrillation in 5% of 75-76 year olds, putting them at increased stroke risk.
How to pre-select responders to cardiac resynchronisation therapy?
escardio.org, 31 August 2014
This session was informative and addressed the controversial issue concerning patient selection for CRT in a lively and provocative fashion.
Recruitment to the Quality Standard Advisory Committee for a suite of CVD topics
Recruitment for specialist membership of the suite of CVD quality standards Quality Standard Advisory Committee (QSAC) starts today and we are seeking applications for the following roles:
• Cardiac Rehabilitation Nurse
Information on the posts is available on the NICE website, please follow this link for details:
The deadline for applications is 17th September at 17.00.
Diabetes increases risk of atrial fibrillation
clinicalendocrinologynews.com, 31 August 2014
Adults with diabetes mellitus are at increased risk of subsequent new-onset atrial fibrillation – and the younger the age at diabetes onset, the greater the likelihood of developing the arrhythmia.
Rapid Uptake of New Oral Anticoagulants in AF Patients
medscape.com, 22 August 2014
Physicians treating patients with atrial fibrillation (AF) have enthusiastically embraced the new oral anticoagulants, with more than 60% of all new prescriptions in June 2013 being filled for dabigatran (Pradaxa, Boehringer Ingelheim), rivaroxaban (Xarelto, Bayer Pharma/Janssen Pharmaceuticals), and apixaban (Eliquis, Bristol-Myers Squibb/Pfizer).
Latest ICDs give heart patients greater security
deccanchronicle.com, 28 August 2014
Patients with implanted pacemakers are usually denied access to MRI (Magnetic resonance imaging) because of the potential harmful interaction between the device and the MRI scanner.
Remote monitoring of implanted pacemakers and defibrillators: an interview with Dr. Suneet Mittal
news-medical.net, 27 August 2014
Remote monitoring is the ability to follow patients who have implantable pacemakers or defibrillators from home. This technology was introduced in the U.S. in 2001 so it’s been available for close to 15 years.
AF mortality and morbidity high at 1 year despite good anticoagulant use
eurekalert.org, 31 August 2014
Barcelona, Spain: Mortality and morbidity of atrial fibrillation (AF) patients remains high at one year despite good use of oral anticoagulants, according to the one year follow up of the Atrial Fibrillation General Pilot Registry. The findings were presented for the first time at ESC Congress 2014 today by registry chairperson Professor Gregory Lip (Birmingham, UK).
CRT, ICD devices reduced mortality regardless of race, ethnicity
healio.com, 21 August 2014
The use of cardiac resynchronization therapy devices and implantable cardioverter defibrillators was associated with reduced mortality at 24 months, regardless of race or ethnicity, according to new data from the IMPROVE HF registry.
AliveCor receives first FDA clearance to detect a serious heart condition in an ECG on a mobile device
AliveCor News Release, 21 August 2014
Patients are able to instantly identify atrial fibrillation in real-time ECG recordings.
Commonly prescribed antibiotic 'could increase risk of cardiac death'
medicalnewstoday.com, 20 August 2014
A new study published in The BMJ has linked a commonly prescribed antibiotic - clarithromycin - to an increased risk of cardiac death.
Get savvy to syncope
americannursetoday.com, August 2014
Usually benign, syncope can sometimes reflect a more serious condition.
Scientists uncover key clue for protecting hearts against deadly arrhythmia
medicalxpress.com, 18 August 2014
A study, funded by the British Heart Foundation (BHF) and Medical Research Council, has shed new light on how carbon monoxide could be used to protect against life-threatening arrhythmias after a heart attack.
Sports for young patients with implantable cardioverter defibrillators: Refining the risk
cxvascular.com, 14 August 2014
Despite a dearth of research, published guidelines in the United States and Europe—based on expert opinion—recommend against competitive sports participation in activities more strenuous than bowling or golf (Class IA) for patients with pacemakers or implantable cardioverter defibrillators (ICDs).
Anticoagulant-associated ICH: management still a challenge
medscape.com, 8 August 2014
Intracerebral hemorrhage (ICH) is often deadly, even more so when it occurs in patients receiving oral anticoagulant (OAC) therapy.
Research survey: help science and win an iPad AirOpen exclusively to Healthcare Professionals, August 2014
VISUALizE (Visualizing Uncertainty Among Laypersons and Experts) is a European wide study seeking to improve understanding of advantages and possible side effects of medicines. This is important for patients and healthcare professionals to choose the most appropriate medicine.
One of the three disease areas that are included in the research is atrial fibrillation (AF). We invite patients and healthcare professionals in this field to complete and submit an online questionnaire. Completing this may take between 30 minutes, however, it is possible to save the form and return to complete it in sections at later dates.Healthcare professionals who complete the questionnaire will be enrolled in a lottery in which the prize being offered is an iPad Air. There will be 10 iPads included in the prize draw.
The questionnaire will be strictly confidential and remain anonymous. To view the questionnaire, please click hereThe scientists leading the VISUALizE study come from the European Medicines Agency, the University of Groningen, the University of Utrecht, the Danish Medicines Agency, Laser Analytica, and pharmaceutical companies Sanofi and Amgen.
Your help is greatly appreciated and will help inform and improve future medicine management!Complete survey
Two devices to achieve LAA occlusion may be feasible
healio.com, 8 August 2014
Patients with nonvalvular atrial fibrillation who received two devices to attain left atrial appendage occlusion had encouraging outcomes, according to findings published in EuroIntervention.
Diploma in Syncope and Related Disorders
RCPI Postgraduate Medical Education Centre, Dublin - September 2014-May 2015
Developed by Prof Rose Anne Kenny and Dr Conal Cunningham together with an international guest faculty, this course has been designed for healthcare professionals, from consultants and registrars to GPs and clinical nurse specialists, with an interest in syncope.
Dosing the New Oral Anticoagulants in Atrial Fib: Can We Do Better?
medscape.com, 4 August 2014
NEW YORK, NY — "Oral administration, please, but no cumbersome dosing strategies" could have been the tag line of the research community that spent decades looking for a more user-friendly alternative that is at least comparable to warfarin in effectiveness and safety. And there's broad agreement, perhaps not universal, that those conditions were met or exceeded in the pivotal stroke-prevention trials presented to regulators in Europe and North America who approved the thrombin inhibitor dabigatran (Pradaxa, Boehringer Ingelheim) and factor Xa inhibitors rivaroxaban (Xarelto, Bayer) and apixaban (Eliquis, Pfizer/Bristol-Myers Squibb) for patients with nonvalvular atrial fibrillation (AF).
Public registration facility to observe the NICE committee meeting for Dual-chamber pacemakers for treating symptomatic bradycardia due to sick sinus syndrome without atrioventricular block now OPEN
NICEcomms, 5 August 2014
If you would like to register for this committee meeting, please click below. Registration for this meeting will close on Tuesday 19 August at 5.00pm. Please note we may be unable to accept late requests to observe this meeting.
Brugada Syndrome Update: More Common Than Imagined
medscape.com, 31 July 2014
Those who know me know that I love ECGs. I love reading about them, writing about them, and talking about them. A major reason for this infatuation is that the ECG is arguably the most important test in acute care medicine.
Catheter ablation helps atrial fibrillation patients live longer
medicalnewstoday.com, 31 July 2014
A new long-term study suggests that adult patients with atrial fibrillation whose heart rhythm is successfully restored with a minimally invasive procedure called catheter ablation, have a significantly reduced chance of early death from a heart attack or heart failure.
BJC Update - Anticoagulation
BJC, 31 July 2014
We report highlights from this year’s British Cardiovascular Society 2014 Annual Conference held on June 2nd–4th 2014. Sessions from the busy programme varied from ‘Cardiology Rocks’ to interactive educational facilities and a multi-modality imaging village.
Radiation therapy examined as future treatment for AF, hypertension
healio.com, 25 July 2014
Early-stage studies indicate that radiation therapy could become a noninvasive alternative treatment for atrial fibrillation and treatment-resistant hypertension.
Simple pulse measure can detect AF after stroke
medscape.com, 24 July 2014
Simple measurement of the peripheral pulse (MPP) at the radial artery is an effective screening tool for diagnosis of atrial fibrillation (AF) in patients who have had a stroke, a new pilot study suggests.
Moderate alcohol use associated with increased risk for atrial fibrillation
cxvascular.com, 18 July 2014
Even in moderation, consumption of wine and hard liquor may be a risk factor for atrial fibrillation, according to new research recently published in the Journal of the American College of Cardiology. The research did not identify a similar risk for moderate consumption of beer.
High self-competence may act as a protective factor against lower quality of life in children with pacemakers
cxvascular.com, 16 July 2014
A low sense of self-competence seems to contribute to decreased quality of life for paediatric patients with pacemakers, according to results of a study recently published in the Journal of Developmental & Behavioral Pediatrics.